Rating History for Centessa Pharmaceuticals (CNTA) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/31/2026 | Rudy Li | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
27.58 (40.50) |
46.85% | Details |
 |
|||||||
